Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Superstatin threat to GP budgets

Government heart tsar Dr Roger Boyle has warned GPs that they may have to prescribe a new generation of

'superstatins', which could put prescribing budgets under even more pressure.

Speaking at last month's National Association of Primary Care conference held in Manchester, Dr Boyle said the cost of prescribing the new drugs could have a knock-on effect on prescribing overspends, which 'were going to get worse'.

Dr Boyle said latest figures showed statin prescribing was costing the NHS £40-50 million per month. Spending on the drugs was highest in Cheshire and Merseyside and lowest in the Thames Valley, he added.

Dr John Pittard, secretary of the Primary Care Cardiovascular Society and a GP in Staines, Middlesex, said superstatins might prove unnecessary because of new 'add-on' lipid-lowering drugs, prescribed on top of a statin. These were due to be licensed soon and had been shown to reduce cholesterol levels by a further 17-18 per cent.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say